Company Active LTD

Company profile

Feebris Ltd

Feebris - Transform Community Care

AI-guided tools that support carers to capture and share precise health measurements enabling more effective care for vulnerable patients.

CRN
10814733
Founded
2017
Age
9

Overview

Legal name
FEEBRIS LTD
Region
South East England
Registered address
NEWFRITH HOUSE
21 HYDE STREET
WINCHESTER
UNITED KINGDOM
SO23 7DR
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
18

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

05 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

22 May
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

26 Nov
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ0NDkyNjM0NGFkaXF6a2N4

Published 26 Nov 2024 12:52

12 Jun
2017

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2019
Funded years
2019, 2020, 2024
Age at first award
1 years

Projects

2024 Innovation Loans Lead participant

AI-Guided Health Checks for Cardio-Respiratory Conditions

1 Feb 2024 to 30 Apr 2026

Awarded
£779,310
Total cost £779,310

At Feebris, we are a transformation partner to health systems that powers safe and effective virtual healthcare. We develop AI-guided software solutions that create capacity for health systems by bringing healthcare to the home. Seven out of ten deaths are caused by chronic conditions, such as heart disease and diabetes, which can be entirely prevented or...

2020 Feasibility Studies Lead participant

Continuity funding to realise an AI-enabled geriatric platform for community health beyond COVID-19

1 Jun 2020 to 30 Nov 2020

Awarded
£207,883
Total cost £207,883

no public description

2020 Feasibility Studies Lead participant

Community Management of COVID-19 in care & nursing homes

1 Jun 2020 to 30 Nov 2020

Awarded
£49,898
Total cost £49,898

Elderly patients, especially with co-morbidities, are particularly vulnerable to COVID-19, with reported mortality rates of 10-20% for those over 70 years. The pandemic is imposing a massive burden on NHS services. Hospital facilities and GP practices have become overloaded and dangerous places for vulnerable people, who are now discharged prematurely or ...

2019 Collaborative R&D Lead participant

AI-enabled geriatric platform for community health

1 Jun 2019 to 28 Feb 2021

Awarded
£744,650
Total cost £1,063,785

"Globally there is a health workforce crisis, with a shortage of 7.2m healthcare professionals. For the NHS this equates to a 50,000 health workforce gap. These shortages result in restricted access to care, lack of personalised and regular assessment, and delayed identification of diseases and exacerbations. The consequences are most severe for the most ...

Product types

Collaborative R&D Feasibility Studies Innovation Loans